Series date: 
09/09/2025 - 12:00pm EDT to 06/30/2026 - 11:59pm EDT

Course Director: Elisabeth Battinelli, MD, PhD

Coordinator: Michael Miller ([email protected]) & Jennifer Carney ([email protected])

For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at [email protected].

You may print individual certificates throughout the year; your cumulative list of sessions attended is accessible on your transcript.


SYSTEMWIDE ACCESS

Link to Mass General Brigham’s Systemwide Grand Rounds Lectures:
https://partnershealthcare.sharepoint.com/sites/VitalsSystemwideGrandRounds


Target Audience:
This activity is intended for physicians & nurses with the specialty of hematology.


ACCREDITATION

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 CreditTM
Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The sessions in this series are being recorded.

Series location: 
Brigham & Women's Hospital
Boston, MA 02115
United States

Sessions

Session Date
11/18 2025, MGB Classical Hematology Grand Rounds 2025-2026, "Cancer associated thrombosis: A tale of unexpected findings," Jeffrey Zwicker, MD 11/18/2025 - 12:00pm to 1:00pm EST
12/16 2025, MGB Classical Hematology Grand Rounds 2025-2026, "Diagnosis of Antiphospholipid Syndrome: laboratory aspects," by Katrien Devreese, MD, PhD 12/16/2025 - 12:00pm to 1:00pm EST
01/20 2026, MGB Classical Hematology Grand Rounds 2025-2026 - "Treatment of Iron Deficiency: A New Paradigm," by Michael Auerbach, MD, FACP 01/20/2026 - 12:00pm to 1:00pm EST
01/27 2026, MGB Classical Hematology Grand Rounds 2025-2026, "Innovations in Platelet (and Platelet-like) Products," Matthew D. Neal, MD, FACS 01/27/2026 - 12:00pm to 1:00pm EST
02/10 2026, MGB Classical Hematology Grand Rounds 2025-2026 "Secondary Prevention of VTE: Abandoning Dichotomies and Embracing Individualized Strategies," by Gregory Piazza, MD, MS 02/10/2026 - 12:00pm to 1:00pm EST
03/03 2026, MGB Classical Hematology Grand Rounds 2025-2026 "Women with Inherited Bleeding Disorders" by Ming Y. Lim, MD 03/03/2026 - 12:00pm to 1:00pm EST
03/10 2026, MGB Classical Hematology Grand Rounds 2025-2026 "Prospects and Challenges for Hemophilia Gene Therapy and Genomic Editing," David Lillicrap, MD, FRCPC 03/10/2026 - 12:00pm to 1:00pm EDT
03/17 2026, MGB Classical Hematology Grand Rounds 2025-2026 "Lipids and their Oxylipins Hold the Key to Discovery of Novel Antiplatelet Targets for Thrombosis," by Michael Holinstat, PhD, FAHA 03/17/2026 - 12:00pm to 1:00pm EDT
03/24 2026, MGB Classical Hematology Grand Rounds 2025-2026 "Platelets: Learning from our Smallest Cells in Big Populations," by Andrew Johnson, Ph.D., FAHA, Senior Investigator, NHLBI, NIH at the Framingham Heart Study 03/24/2026 - 12:00pm to 1:00pm EDT
03/31 2026, MGB Classical Hematology Grand Rounds 2025-2026 "Structural and functional properties of alloantibodies causing fetal/neonatal thrombocytopenia," By Coert Margadant, Ph.D. 03/31/2026 - 12:00pm to 1:00pm EDT

Pages